The Optiflow Patency and Maturation Study
NCT01921933
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
End-stage Kidney Disease
End-stage Renal Disease
Interventions
DEVICE:
Optiflow
Sponsor
Bioconnect Systems, Inc